Associated Papers
Functional characterization and potential therapeutic avenues for variants in the NTRK2 gene causing developmental and epileptic encephalopathies.
Long A et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2022
The central melanocortin system and human obesity.
Yang Y et al.
Journal of Molecular Cell Biology, 2020
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Gudernova I et al.
Oncotarget, 2017
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.
Hamdan FF et al.
American Journal of Human Genetics, 2017
Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies.
da Fonseca ACP et al.
Journal of Diabetes and Its Complications, 2017
Diagnostic value of exome and whole genome sequencing in craniosynostosis.
Miller KA et al.
Journal of Medical Genetics, 2017
Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk.
Kranz TM et al.
Schizophrenia Research, 2015
The genetics of human obesity.
Xia Q et al.
Annals of the New York Academy of Sciences, 2013
Genetic factors for human obesity.
Ichihara S et al.
Cellular and Molecular Life Sciences : Cmls, 2008
Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity.
Gray J et al.
International Journal of Obesity (2005), 2007
A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.
Yeo GS et al.
Nature Neuroscience, 2004
Select a paper to view details